Insulin Delivery
Company launches study in teenagers with diabetes
Published in Obesity and Diabetes Week, December 8th, 2003
The studies will be conducted in North America and Europe. The protocols for these studies have been approved by applicable regulatory agencies.
The target population includes youths failing oral hypoglycemic agents therapy as well as patients on multiple daily injections. The Oralin will be introduced in the treatment plan as a replacement for s.c. injections.
"While the number of patients with diabetes has been growing rapidly, the increase among teenagers is particularly alarming," said Anna Gluskin, CEO of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetic Nephropathy
Beta defensin-1 mRNA elevated in diabetic kidneys of GK rats - Obesity and Diabetes
Resistin levels not associated with obesity or insulin resistance - Diabetes Therapy
Metformin vital for vascular protection in diabetic patients - Obesity Epidemiology
Weight loss programs needed for obese adolescents in Latin America - Obesity Therapy
Repeated prolactin-releasing peptide therapy leads to tolerance - Pediatric Obesity
Leading scientists call for urgent action to prevent epidemic - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
